Arvee Laboratories India Q3 Results 2025:Arvee Laboratories India declared their Q3 results on 12 Feb, 2025, reporting a revenue increase of 15.71% year-on-year but a concerning profit decline of 37.5%. The profit stood at ₹0.15 crore, while revenue reached ₹8.91 crore.
However, when compared to the previous quarter, the company faced significant challenges, with revenue declining by 28.89% and profit plummeting by 84.69%. This troubling trend raises questions about the sustainability of their current financial strategies.
Additionally, the Selling, General & Administrative expenses have risen, increasing by 4.46% quarter-on-quarter and by 19.39% year-on-year. This rise in expenses could further impact profitability if not managed effectively.
The operating income also showed a stark decrease, down by 94.17% quarter-on-quarter and 58.82% year-on-year, indicating a substantial contraction in operational performance.
Earnings per share (EPS) for Q3 is reported at ₹0.14, which represents a decrease of 36.36% year-on-year. This decline in EPS signals a potential decrease in investor confidence moving forward.
Arvee Laboratories India has delivered a return of -2.5% in the last week, -23.37% in the last six months, and a -16.4% return year-to-date, showcasing a troubling trend for investors.
Currently, Arvee Laboratories India holds a market capitalization of ₹153.29 crore, with a 52-week high of ₹315 and a low of ₹117.05. This volatility reflects the challenges the company faces in the competitive market.
Arvee Laboratories India Financials
| Period | Q3 (FY25) | Q2 (FY25) | Q-o-Q Growth | Q3 (FY24) | Y-o-Y Growth |
|---|---|---|---|---|---|
| Total Revenue | 8.91 | 12.53 | -28.89% | 7.7 | +15.71% |
| Selling/ General/ Admin Expenses Total | 1.17 | 1.12 | +4.46% | 0.98 | +19.39% |
| Depreciation/ Amortization | 0.28 | 0.3 | -6.67% | 0.35 | -20% |
| Total Operating Expense | 8.84 | 11.32 | -21.91% | 7.53 | +17.4% |
| Operating Income | 0.07 | 1.2 | -94.17% | 0.17 | -58.82% |
| Net Income Before Taxes | 0.21 | 1.31 | -83.97% | 0.32 | -34.38% |
| Net Income | 0.15 | 0.98 | -84.69% | 0.24 | -37.5% |
| Diluted Normalized EPS | 0.14 | 0.89 | -84.27% | 0.22 | -36.36% |
Disclaimer: This is an AI-generated live blog and has not been edited by LiveMint staff.
#Arvee #Laboratories #India #Results #Feb #profit #falls #YOY #profit #crore #revenue #crore #Company #Business #News
Arvee Laboratories India Q3 result, Arvee Laboratories India, Arvee Laboratories India Q3, Arvee Laboratories India Quarterly Result, Q3 Result
latest news today, news today, breaking news, latest news today, english news, internet news, top news, oxbig, oxbig news, oxbig news network, oxbig news today, news by oxbig, oxbig media, oxbig network, oxbig news media
HINDI NEWS
News Source
